Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2015 / Oct / A Crystal Clear View
Neurology Neurology Microscopy and imaging

A Crystal Clear View

Liquid crystal displays are ubiquitous, but could the technology be used to detect early-stage amyloid fibril formation?

By Roisin McGuigan 10/23/2015 1 min read

Share

Most of us are familiar with liquid crystals as a technology involved in creating television and computer screens, but now, researchers at the University of Chicago’s Institute for Molecular Engineering have found a very different use for them – detecting amyloid fibrils, which are widely implicated in neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s (1), and are also suspected of playing a role in type 2 diabetes (2). Current methods for detecting amyloid fibrils are less than ideal – the fibers are thought to be at their most toxic early on in their formation, when they are still too small to study using optical microscopy. This means costly and complex techniques using fluorescence or neutron scattering are required.

Liquid crystals could provide a simple and relatively inexpensive way to study the tiny fibers, according to the University researchers. The method exploits the way the crystals respond to surface disturbances – a light-blocking layer is added to a film of liquid crystals, and on top of this a membrane, covered in water, is added. The molecules that form the toxic amyloid aggregates are injected into the water layer, and as the aggregates form and grow on the membrane, they imprint their shape into the liquid crystal underneath. This distorts the molecules present in the light-blocking layer, allowing light to shine through, explains co-author of the associated paper (3), Juan de Pablo. Though the fibers themselves are still too small to view, their effect is magnified by the imprint they leave, and is large enough to view using a simple optical microscope. “The liquid crystal is actually reporting what’s happening to the aggregates at the interface, and these bright spots become bigger and adopt the shape of the actual fibers that the protein is forming. Except you’re not seeing the fibers, you’re seeing the liquid crystal’s response to the fibers,” says de Pablo.

The team is now working on a way to use their method in emulsion as opposed to a flat surface, and they hope that eventually the technology could be used to create a method for testing small samples of blood or other body fluids, or to study the effects of different drugs on aggregate growth. “For research in type 2 diabetes, or Alzheimer’s or Parkinson’s, having this simple platform to perform these tests at a fraction of the cost of what’s required for fluorescence or neutron scattering would be very useful,” says de Pablo.

Newsletters

Receive the latest analytical scientist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. M Stefani, “Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer’s disease and other diseases with amyloid deposits”, Prog Neurobiol, 99, 225–245 (2012). PMID: 22450705. A Mukherjee, et al., “Type 2 diabetes as a protein misfolding disease”, Trends Mol Med, 21, 439–449 (2015). PMID: 25998900. M Sadati, et al., “Liquid crystal enabled early stage detection of beta amyloid formation on lipid monolayers”, Adv Funct Mater, 25, 6050–6060 (2015).

About the Author(s)

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as an Associate Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

More Articles by Roisin McGuigan

Explore More in Analytical Science

Dive deeper into the analytical science. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Shapeshifting Cancer
Neurology
The Shapeshifting Cancer

February 24, 2022

1 min read

Understanding the heterogeneity and plasticity of glioblastoma

Image of the Month
Neurology
Image of the Month

October 21, 2016

1 min read

Who Will Be The Caretakers?
Neurology
Who Will Be The Caretakers?

August 4, 2022

3 min read

Recent allegations of image manipulation in a major Alzheimer’s disease paper reaffirm the importance of research integrity

Getting to the Genetic Core of Autism
Neurology
Getting to the Genetic Core of Autism

August 15, 2022

2 min read

Investigating the genotype-phenotype relationship in autism to improve our understanding of heterogeneity

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.